**Verdict: ACCEPT. No required findings.**

Reviewed X10 r3, `docs/implementation/m2/read-cli-x10/PROPOSAL.md`, 16,059 bytes, SHA-256 `0f263d12d38d2d43f8dfe5f999efbbd9f79f2f3fbd3145ef7c3804c39804fca2`. The subject matches the r3 request's pin. I diffed it against `PROPOSAL-r2.md`, whose SHA-256 `a1ee7ce72a110f33bc441c6a1f6ef6e6a8fb3efb69c0f849b4c46c117cb6fa16` matches the previously reviewed r2 bytes.

Product HEAD remains `fdbedf4acc7ef57fb71eed424c3b08fa2af7fe98`, unchanged since the r2 review. This accepts the law; implementation and its tests remain the subsequent code unit's work.

**All prior findings are closed.**

| Finding | Closure |
|---|---|
| RF-1 — nested doctor kind | Remains closed. Item 3, line 40, preserves the assembled result in both report branches, including nested `kind: "doctor"`. Item 7, line 95, retains missing/wrong-kind negative schema checks. |
| RF-2 — complete outcome parity | Closed. Item 4, line 62, explicitly shares termination rendering with doctor reports and includes the fault cause when present. Request-rejected output invents none. The errors blocks retain their detail, subject and remedy, and line 65 requires complete termination parity for refused as well as report outcomes. This covers the busy, host-I/O and budget fault causes that the r2 layout omitted. |
| RF-3 — test arrangement and coverage | Closed. Item 5 now confines security tests to real Complete/Incomplete observations and refusal rows. Host tests distinguish native-shaped inputs from explicitly synthetic DomainDetail vectors, preserving the mixed-complete, complete 255+note/256 and partial 256/257 cases. Production still passes `other=[]`. Item 8, lines 98–99, replaces the retired `run_with` deliverable with the single-producer ingress and layered tests. |

The layered arrangement is buildable against the reviewed crate interfaces without exposing private security fixtures to host. Security unit tests retain their own scratch-home/profile producers. Host tests consume the public observation/refusal types and use the existing `doctor_installation`/assembler inputs for synthetic report cases. Binary tests exercise the native development-build path. The law accurately states that no single test composes real scratch-home producers through the host renderer; synthetic report coverage is not represented as native producer coverage.

The revision introduces no home/profile/release selector, feature bridge or new public capability. The ingress remains bound to exactly one `observe_installation_for_doctor()` call, with production `other=[]`, and the no-override/source-pin obligations remain. These are implementation requirements, not a claim that a future release binary has already been tested.

I found no new required issue in the diff or the complete r3 proposal. The unchanged scope, envelope/refusal mapping, exact informational label, count/slot rules, help/completion plan, source-schema validation and X11 backup-carrier deferral remain acceptable. The lead's decisions and rejected alternatives remain consistent with the accepted scope.

The previously identified golden reconciliation remains work already provided for by item 8: select the applicable doctor remedy texts and reconcile the not-producible situation before accepting enabled CLI output. Accepting this law does not select the current assembler constants as golden overrides. This is not an additional law finding. The previously noted description of both empty-errors exceptions as metadata-only is still an explanatory imprecision with no effect on the specified doctor rows.

**Verification scope.**

I verified the r3 subject pin, the preserved r2 pin, the full r2-to-r3 diff, the current product HEAD, and consistency with the source/API and schema evidence from r1/r2. The product source and envelope shapes did not change, so I did not repeat the already successful in-memory schema checks. Those checks established that the corrected unproducible envelope is valid, missing/altered nested kind is invalid, and busy, host-I/O and budget refusal shapes are valid. Rendering and test implementation are still to be reviewed and executed in X10a.

No Cargo command, product build, native installation observation, repository edit, commit, push or delegation was performed. Only `REVIEW.md` and `review.json` were written under the requested r3 review directory.
